These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2093382)
21. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy. Belardinelli R; Cianci G; Gigli M; Mazzanti M; Lacalaprice F J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390 [TBL] [Abstract][Full Text] [Related]
22. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention. Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885 [TBL] [Abstract][Full Text] [Related]
23. [Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study]. Passeron J Presse Med; 1986 Oct; 15(35):1775-8. PubMed ID: 2947149 [TBL] [Abstract][Full Text] [Related]
24. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710 [TBL] [Abstract][Full Text] [Related]
25. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris. Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987 [TBL] [Abstract][Full Text] [Related]
26. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study. Rosano GM; Vitale C; Sposato B; Mercuro G; Fini M Cardiovasc Diabetol; 2003 Nov; 2():16. PubMed ID: 14641923 [TBL] [Abstract][Full Text] [Related]
27. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy. Wisenbaugh T; Katz I; Davis J; Essop R; Skoularigis J; Middlemost S; Röthlisberger C; Skudicky D; Sareli P J Am Coll Cardiol; 1993 Apr; 21(5):1094-100. PubMed ID: 8096228 [TBL] [Abstract][Full Text] [Related]
28. Clinical benefits of a metabolic approach in the management of coronary patients. Marzilli M Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V25-30. PubMed ID: 11206100 [TBL] [Abstract][Full Text] [Related]
29. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions. McClellan KJ; Plosker GL Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934 [TBL] [Abstract][Full Text] [Related]
30. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study. Sellier P; Broustet JP Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070 [TBL] [Abstract][Full Text] [Related]
31. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure. Fragasso G; Salerno A; Lattuada G; Cuko A; Calori G; Scollo A; Ragogna F; Arioli F; Bassanelli G; Spoladore R; Luzi L; Margonato A; Perseghin G Heart; 2011 Sep; 97(18):1495-500. PubMed ID: 21700755 [TBL] [Abstract][Full Text] [Related]
32. Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease. Lu C; Dabrowski P; Fragasso G; Chierchia SL Am J Cardiol; 1998 Oct; 82(7):898-901. PubMed ID: 9781975 [TBL] [Abstract][Full Text] [Related]
33. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy. Belardinelli R; Purcaro A Eur Heart J; 2001 Dec; 22(23):2164-70. PubMed ID: 11913478 [TBL] [Abstract][Full Text] [Related]
34. Role of trimetazidine in management of ischemic cardiomyopathy. Bertomeu-Gonzalez V; Bouzas-Mosquera A; Kaski JC Am J Cardiol; 2006 Sep; 98(5A):19J-24J. PubMed ID: 16931202 [TBL] [Abstract][Full Text] [Related]
35. [Current concepts in cellular ischemia: role of trimetazidine]. Gallet M Ann Cardiol Angeiol (Paris); 1986 Oct; 35(7 Pt 2):459-62. PubMed ID: 3800288 [TBL] [Abstract][Full Text] [Related]
36. Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting. Tünerir B; Colak O; Alataş O; Beşoğul Y; Kural T; Aslan R Ann Thorac Surg; 1999 Dec; 68(6):2173-6. PubMed ID: 10616997 [TBL] [Abstract][Full Text] [Related]
37. [Effectiveness of trimetazidine in patients with hypertension and the symptoms of coronary disease]. Kozakiewicz K; Petelenz T; Chruściel TL Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):594-6. PubMed ID: 1488335 [TBL] [Abstract][Full Text] [Related]
38. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris]. Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118 [TBL] [Abstract][Full Text] [Related]
39. [Therapeutic value of a combination of trimetazidine with a calcium inhibitor in the treatment of chronic coronary insufficiency]. Deroux A; Brochier M; Demange J; Ducloux G; Monpère C; Warin JF Presse Med; 1986 Oct; 15(35):1783-7. PubMed ID: 2947151 [TBL] [Abstract][Full Text] [Related]
40. Clinical benefits of trimetazidine in patients with recurrent angina. Szwed H Coron Artery Dis; 2004 May; 15 Suppl 1():S17-21. PubMed ID: 15179124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]